Vimarsana
Biggest News Aggregation in the World

Page 3 - Mao Chen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mao Chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mao Chen Today - Breaking & Trending Today

Venus Medtech (Hangzhou) Inc.: First American Patient Treated with VenusP-Valve Under Compassionate Use - Vimarsana News

Venus Medtech (Hangzhou) Inc.: First American Patient Treated with VenusP-Valve Under Compassionate Use

HANGZHOU, China, June 22, 2022 /PRNewswire/ -- VenusP-Valve, an in-house developed novel medical device of Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as "Venus Medtech")

First American Patient Treated with VenusP-Valve Under Compassionate Use - Vimarsana News

First American Patient Treated with VenusP-Valve Under Compassionate Use

HANGZHOU, China, June 22, 2022 /PRNewswire/ -- VenusP-Valve, an in-house developed novel medical device of Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as "Venus Medtech"), recently completed its first compassionate use at University of Virginia Advanced Cardiac Valve Center in the U.S. The procedure was performed at the Center by Professor Scott Lim's team under on-site guidance from Professor Yuan Feng and remote guidance from Professor Mao Chen, who are both from Cardiology Department, West China Hospital, Sichuan University in China. As the first-ever clini...

First American Patient Treated with VenusP-Valve™ Under Compassionate Use - Vimarsana News

First American Patient Treated with VenusP-Valve™ Under Compassionate Use

HANGZHOU, China, June 22, 2022 /PRNewswire/ -- VenusP-Valve™, an in-house developed novel medical device of Venus Medtech (Hangzhou) Inc. (2500.HK...

First Successful Clinical Mitral Valve Replacement - Vimarsana News

First Successful Clinical Mitral Valve Replacement

On December 22, 2021, the first clinical case using HighLife transseptal mitral valve replacement (TSMVR) technology was successfully carried out in Asia. The implantation of Peijia's Highlife TSMVR system was performed by Professor Mao Chen and his team of West China Medical Center of Sichuan University as part of a research clinical trial. - Click here if this is your press release! - eTurboNews | Trends | Travel News

Peijia Medical's New Milestone Asia's first successful clinical case using HighLife transseptal mitral valve replacement technology - Vimarsana News

Peijia Medical's New Milestone Asia's first successful clinical case using HighLife transseptal mitral valve replacement technology

/PRNewswire/ -- On December 22, 2021, the first clinical case using HighLife transseptal mitral valve replacement ("TSMVR") technology was successfully carried...